Skip to search formSkip to main contentSkip to account menu

alloimmunity

Known as: isoimmunity 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Innate Alloimmunity - Part 2: Innate Immunity and Allograft Rejection
T he origin of allograft injury is difficult to ascertain. Incipient damage may occur before organ implantation and progress… 
2011
2011
Detection Of Antisperm Antibodies By Elisa System In The Cervical Mucus Of Women With Unexplained Infertility
Background and Objectives: Unexplained infertility occurs in many couples of childbearing age, immune mechanisms have been… 
2008
2008
Allograft Immune Reaction of Kidney Transplantation Part 2. Immunosuppression and Methods to Assess Alloimmunity
이식을 위해서는 수여자와 공여자의 혈액형과 HLA type을 알아야 한다. 통상 ABO 혈액형이 적합한 경우 이식할 수 있으며 HLA 부적합은 근래 큰 문제가 되지 않으나 HLA… 
1996
1996
Islet and pancreatic transplantation--autoimmunity and alloimmunity.
Given the autoimmune cause of insulin-dependent diabetes mellitus,1 the theoretical barriers to successful pancreatic and islet… 
1983
1983
THE ABILITY OF INTERSPECIES CROSSREACTIVE ANTI‐Ia MURINE ALLOANTIBODIES TO ELIMINATE A SUBPOPULATION OF HUMAN ADHERENT CELLS RESPONSIBLE FOR INDUCTION OF ALLOIMMUNITY
Certain anti-la murine alloantibodies react with the Ia-positive B cells of almost all mammalian species. In this report, the… 
1979
1979
Immunity: autoimmunity, isoimmunity, and immunodeficiency in the foal.
Review
1974
Review
1974
Sperm antibody production in female sterility.
A review of the immunological implications in reproductive physiology is presented. Although attempts have been made to ascribe… 
1973
1973
REJECTION AND ENHANCEMENT IN AN IN VITRO MODEL OF ALLOIMMUNITY: Comparison of F1 and Parental Strains
SUMMARY A 4-hr quantitative assay for alloimmune lymphocyte-mediated cytotoxicity (LMC) using 51Cr-labeled thymocyte target cells… 
1962
1962
On the question of the mechanism of growth of a tumour against isoimmunity.
1961
1961
Isoimmunity against an induced primary tumour.